Trxade Health Inc (NASDAQ: MEDS) stock enjoyed a major increase of 10.8% on 10/28/24. The shares closed at $8.20. Moreover, exceptionally high trading volume at 234% of normal accompanied the advance. The stock has risen 21.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
MEDS is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Trxade Health has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Trxade Health has a slightly negative Power Rating of 34 and a very low Appreciation Score of 2, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment